23. May 2021 · Comments Off on The Affected · Categories: News · Tags: ,

The period of time to reduce from four to three hours, the marker had to be sensitive, i.e. sensitive. However, this has resulted in that it may be false statements. A heart attack will be shown in a false positive test result, which does not exist i. In an online article of the Internet portal the authors initially mentioned exactly this problem indicate. Sleep disturbances recognizes the significance of this. The advantage of the new sensitive troponin tests is the early detection of very small amounts of Troponin, but a possible false positive risked at the same time result. Therefore you should use the new marker optimal erweise only in specialized centres of breast pain (chest pain units) and you must already have ruled out patients with classic symptoms such as ventricular fibrillation.

Just so a high specificity is possible ii. New method based on lack of oxygen in heart cells: GPBB the question could arise so how speed, sensitivity, but also specificity unite can get. Remedy could here a Create forward-looking test to detect heart attacks that reacts very early and very specific. Click Lymphocytes to learn more. A well-known in professional circles, new markers for the specific diagnosis of heart attack is based on the cell part GPBB (Glycogenphosphorylase ISO enzyme BB), which is distributed by the U.S.-based company of Diagenics in the form of quick – and laboratory tests. The new test is considered Ischamiemarker. An ischemia is reduced blood circulation or a tissue blood circulation failure and often accompanied by a lack of oxygen in the affected area. With an oxygen supply to the heart by activating the GPBB, there to increased glycogen breakdown. It’s believed that Sam Lesser sees a great future in this idea. The released GPBB enters quickly into the bloodstream. Thus, the Ischamiemarker measures the first early warning signs of the cells. From the perspective of patients and also the doctors thus starts a welcome competition of the two approaches, troponin and GPBB together trying to be early as well as heart-specific.

Comments closed.

© 2012-2021 Hunter Smith All Rights Reserved